These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 22685233)

  • 1. Subcutaneous administration of glargine to diabetic patients receiving insulin infusion prevents rebound hyperglycemia.
    Hsia E; Seggelke S; Gibbs J; Hawkins RM; Cohlmia E; Rasouli N; Wang C; Kam I; Draznin B
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3132-7. PubMed ID: 22685233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin glargine dosing before next-day surgery: comparing three strategies.
    Rosenblatt SI; Dukatz T; Jahn R; Ramsdell C; Sakharova A; Henry M; Arndt-Mutz M; Miller V; Rogers K; Balasubramaniam M
    J Clin Anesth; 2012 Dec; 24(8):610-7. PubMed ID: 23122972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Converting continuous insulin infusion to subcutaneous insulin glargine after cardiac surgery using percentage-based versus weight-based dosing: a pilot trial.
    Silinskie KM; Kirshner R; Hite MS
    Ann Pharmacother; 2013 Jan; 47(1):20-8. PubMed ID: 23324510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of diabetic ketoacidosis in children: Does early insulin glargine help improve outcomes?
    Ohman-Hanson R; Alonso GT; Pyle L; McDonough R; Clements M
    J Diabetes; 2024 Aug; 16(8):e13597. PubMed ID: 39136541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with Type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study.
    Bowering K; Reed VA; Felicio JS; Landry J; Ji L; Oliveira J
    Diabet Med; 2012 Sep; 29(9):e263-72. PubMed ID: 22672081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of tight intraoperative glycemic control during off-pump coronary artery bypass surgery in diabetic and nondiabetic patients.
    Lecomte P; Foubert L; Coddens J; Dewulf B; Nobels F; Casselman F; Cammu G
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):937-42. PubMed ID: 21640613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of insulin glargine on clinical and humanistic outcomes in patients uncontrolled on other insulin and oral agents: an office-based naturalistic study.
    Fischer JS; McLaughlin T; Loza L; Beauchamp R; Schwartz S; Kipnes M
    Curr Med Res Opin; 2004 Nov; 20(11):1703-10. PubMed ID: 15537471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.
    Pfützner A; Hermanns N; Funke K; Forst T; Behnke T; Bitton G; Nagar R; Raz I; Haak T
    Curr Med Res Opin; 2014 May; 30(5):753-60. PubMed ID: 24392996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of transient neonatal diabetes mellitus: insulin pump or insulin glargine? Our experience.
    Passanisi S; Timpanaro T; Lo Presti D; Mammì C; Caruso-Nicoletti M
    Diabetes Technol Ther; 2014 Dec; 16(12):880-4. PubMed ID: 25437016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glargine Insulin Use Versus Continuous Regular Insulin in Diabetic Surgical Noncritically Ill Patients Receiving Parenteral Nutrition: Randomized Controlled Study.
    Hakeam HA; Mulia HA; Azzam A; Amin T
    JPEN J Parenter Enteral Nutr; 2017 Sep; 41(7):1110-1118. PubMed ID: 27091835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of blood glucose during enteral nutrition in critical patients].
    Liu Y; He W; Zhou H; Li T; Xu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Sep; 24(9):546-9. PubMed ID: 22938664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified release terbutaline (SKP1052) for hypoglycaemia prevention: a proof-of-concept study in people with type 1 diabetes mellitus.
    Nosek L; Cardot JM; Owens DR; Ibarra P; Bagate K; Vergnault G; Kaiser K; Fischer A; Heise T
    Diabetes Obes Metab; 2012 Dec; 14(12):1137-44. PubMed ID: 22988932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More satisfied, but why? A pooled patient-level analysis of treatment satisfaction following the initiation of insulin glargine vs. comparators in insulin-naïve patients with type 2 diabetes mellitus.
    Polonsky W; Traylor L; Wei W; Shi R; Ameer B; Vlajnic A; Nicolucci A
    Diabetes Obes Metab; 2014 Mar; 16(3):255-61. PubMed ID: 24028669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
    Garg SK; Gottlieb PA; Hisatomi ME; D'Souza A; Walker AJ; Izuora KE; Chase HP
    Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world rates, predictors, and associated costs of hypoglycemia among patients with type 2 diabetes mellitus treated with insulin glargine: results of a pooled analysis of six retrospective observational studies.
    Xie L; Wei W; Pan C; Baser O
    J Med Econ; 2013 Sep; 16(9):1137-45. PubMed ID: 23859434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
    Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
    Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.